Tech stocks experienced a significant surge on Monday, with the Nasdaq 100 achieving its best performance since early August. The broader Nasdaq Composite index rose 2.2%, reaching an all-time closing high, while the S&P 500 and Dow Jones also posted notable gains. The market's…
As markets approach the Labor Day weekend, analysts from Wall Street have made significant calls on various stocks, including upgrades for Broadcom, Deere & Company, and Dell Tech…
Moderna's shares rose by 2.9% in pre-market trading as they rebounded from a recent decline. This follows a significant rally triggered by positive Phase 3 trial results for its p…
Despite a significant increase in Merck's stock price following strong Q2 earnings, an unusual volume of put options has been traded, suggesting investor concerns about potential…
Moderna's stock experienced a significant increase of more than 90% in premarket trading after the company announced positive results from a Phase 3 trial of its personalized mRNA…
Researchers at MIT have developed a new formulation for lipid nanoparticles that stabilize RNA vaccines, allowing them to withstand higher temperatures. This advancement could fac…
BioNTech SE's stock fell by 8% after the company halted its Phase 2 colorectal cancer vaccine trial due to futility. This decision has also affected other mRNA vaccine stocks, inc…
On August 19, 2026, Wall Street rebounded from a three-day decline as Treasury yields fell following an announcement from the US Treasury Department regarding increased purchases…
The nomination of Dr. Erica Schwartz as the new CDC Director comes with promises of clear public health guidance, all while navigating the turbulent waters of vaccine skepticism a…